private:barofold
|
2394815
|
May 22nd, 2019 12:00AM
|
BaroFold, Inc.
|
112
|
3.00
|
Open
|
Biotechnology
|
May 22nd, 2019 12:58PM
|
May 22nd, 2019 12:58PM
|
BaroFold was founded in 2009 by Matt Brewer and Matt Seefeldt through the acquisitions of a new company and is based on the patented PreEMT technology invented at the University of Colorado in the laboratories of Dr. Ted Randolph and Dr. John Carpenter. The Company is located at the Fitzsimons Bioscience Park in Aurora, CO and enjoys ample access to talented researchers within the biotech corridor between Denver and Boulder.
BaroFold provides the leading solution for solving the challenges of protein refolding and aggregation and enables E coli cytoplasmic expression to be the most efficient and cost effective expression technology when glycosylation is not required. BaroFold’s contract research services leverage a scalable, cGMP validated, Pressure Enabled Protein Manufacturing Technology (PreEMT™) for accelerating biologic drug development by reversing protein aggregation.
BaroFold helps companies create novel protein therapeutics, accelerate therapeutic protein development and manufacture follow-on biologics where access to a novel process technology is critical.
BaroFold manufactures state of the art PreEMT units for laboratory research and client clinical production requirements. All of BaroFold's units have successfully completed multiple GMP development runs for clinical supply and are available for licensing.
|
Open
|
Protein refolding/disaggregation, Protein analytical and aggregate characterization, Microbial expression and process development, Formulation stability and immunogenicity studies
|
Open
|
|
|
|
|
|
|
BaroFold
|
|
Health Care Equipment & Services
|
private:barofold
|
2394815
|
Mar 19th, 2018 12:00AM
|
BaroFold, Inc.
|
105
|
5.00
|
Open
|
Biotechnology
|
Mar 19th, 2018 06:46AM
|
Mar 19th, 2018 06:46AM
|
|
Open
|
|
|
|
|
|
|
|
|
BaroFold
|
|
Health Care Equipment & Services
|
private:barofold
|
2394815
|
Feb 17th, 2018 12:00AM
|
BaroFold, Inc.
|
98
|
5.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
BaroFold was founded in 2009 by Matt Brewer and Matt Seefeldt through the acquisitions of a new company and is based on the patented PreEMT technology invented at the University of Colorado in the laboratories of Dr. Ted Randolph and Dr. John Carpenter. The Company is located at the Fitzsimons Bioscience Park in Aurora, CO and enjoys ample access to talented researchers within the biotech corridor between Denver and Boulder.
BaroFold provides the leading solution for solving the challenges of protein refolding and aggregation and enables E coli cytoplasmic expression to be the most efficient and cost effective expression technology when glycosylation is not required. BaroFold’s contract research services leverage a scalable, cGMP validated, Pressure Enabled Protein Manufacturing Technology (PreEMT™) for accelerating biologic drug development by reversing protein aggregation.
BaroFold helps companies create novel protein therapeutics, accelerate therapeutic protein development and manufacture follow-on biologics where access to a novel process technology is critical.
BaroFold manufactures state of the art PreEMT units for laboratory research and client clinical production requirements. All of BaroFold's units have successfully completed multiple GMP development runs for clinical supply and are available for licensing.
|
|
|
|
|
|
|
|
|
|
BaroFold
|
|
Health Care Equipment & Services
|
private:barofold
|
2394815
|
Feb 16th, 2018 12:00AM
|
BaroFold, Inc.
|
98
|
5.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
BaroFold was founded in 2009 by Matt Brewer and Matt Seefeldt through the acquisitions of a new company and is based on the patented PreEMT technology invented at the University of Colorado in the laboratories of Dr. Ted Randolph and Dr. John Carpenter. The Company is located at the Fitzsimons Bioscience Park in Aurora, CO and enjoys ample access to talented researchers within the biotech corridor between Denver and Boulder.
BaroFold provides the leading solution for solving the challenges of protein refolding and aggregation and enables E coli cytoplasmic expression to be the most efficient and cost effective expression technology when glycosylation is not required. BaroFold’s contract research services leverage a scalable, cGMP validated, Pressure Enabled Protein Manufacturing Technology (PreEMT™) for accelerating biologic drug development by reversing protein aggregation.
BaroFold helps companies create novel protein therapeutics, accelerate therapeutic protein development and manufacture follow-on biologics where access to a novel process technology is critical.
BaroFold manufactures state of the art PreEMT units for laboratory research and client clinical production requirements. All of BaroFold's units have successfully completed multiple GMP development runs for clinical supply and are available for licensing.
|
|
|
|
|
|
|
|
|
|
BaroFold
|
|
Health Care Equipment & Services
|
private:barofold
|
2394815
|
Feb 15th, 2018 12:00AM
|
BaroFold, Inc.
|
98
|
5.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
BaroFold was founded in 2009 by Matt Brewer and Matt Seefeldt through the acquisitions of a new company and is based on the patented PreEMT technology invented at the University of Colorado in the laboratories of Dr. Ted Randolph and Dr. John Carpenter. The Company is located at the Fitzsimons Bioscience Park in Aurora, CO and enjoys ample access to talented researchers within the biotech corridor between Denver and Boulder.
BaroFold provides the leading solution for solving the challenges of protein refolding and aggregation and enables E coli cytoplasmic expression to be the most efficient and cost effective expression technology when glycosylation is not required. BaroFold’s contract research services leverage a scalable, cGMP validated, Pressure Enabled Protein Manufacturing Technology (PreEMT™) for accelerating biologic drug development by reversing protein aggregation.
BaroFold helps companies create novel protein therapeutics, accelerate therapeutic protein development and manufacture follow-on biologics where access to a novel process technology is critical.
BaroFold manufactures state of the art PreEMT units for laboratory research and client clinical production requirements. All of BaroFold's units have successfully completed multiple GMP development runs for clinical supply and are available for licensing.
|
|
|
|
|
|
|
|
|
|
BaroFold
|
|
Health Care Equipment & Services
|
private:barofold
|
2394815
|
Feb 14th, 2018 12:00AM
|
BaroFold, Inc.
|
98
|
5.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
BaroFold was founded in 2009 by Matt Brewer and Matt Seefeldt through the acquisitions of a new company and is based on the patented PreEMT technology invented at the University of Colorado in the laboratories of Dr. Ted Randolph and Dr. John Carpenter. The Company is located at the Fitzsimons Bioscience Park in Aurora, CO and enjoys ample access to talented researchers within the biotech corridor between Denver and Boulder.
BaroFold provides the leading solution for solving the challenges of protein refolding and aggregation and enables E coli cytoplasmic expression to be the most efficient and cost effective expression technology when glycosylation is not required. BaroFold’s contract research services leverage a scalable, cGMP validated, Pressure Enabled Protein Manufacturing Technology (PreEMT™) for accelerating biologic drug development by reversing protein aggregation.
BaroFold helps companies create novel protein therapeutics, accelerate therapeutic protein development and manufacture follow-on biologics where access to a novel process technology is critical.
BaroFold manufactures state of the art PreEMT units for laboratory research and client clinical production requirements. All of BaroFold's units have successfully completed multiple GMP development runs for clinical supply and are available for licensing.
|
|
|
|
|
|
|
|
|
|
BaroFold
|
|
Health Care Equipment & Services
|
private:barofold
|
2394815
|
Feb 13th, 2018 12:00AM
|
BaroFold, Inc.
|
98
|
5.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
BaroFold was founded in 2009 by Matt Brewer and Matt Seefeldt through the acquisitions of a new company and is based on the patented PreEMT technology invented at the University of Colorado in the laboratories of Dr. Ted Randolph and Dr. John Carpenter. The Company is located at the Fitzsimons Bioscience Park in Aurora, CO and enjoys ample access to talented researchers within the biotech corridor between Denver and Boulder.
BaroFold provides the leading solution for solving the challenges of protein refolding and aggregation and enables E coli cytoplasmic expression to be the most efficient and cost effective expression technology when glycosylation is not required. BaroFold’s contract research services leverage a scalable, cGMP validated, Pressure Enabled Protein Manufacturing Technology (PreEMT™) for accelerating biologic drug development by reversing protein aggregation.
BaroFold helps companies create novel protein therapeutics, accelerate therapeutic protein development and manufacture follow-on biologics where access to a novel process technology is critical.
BaroFold manufactures state of the art PreEMT units for laboratory research and client clinical production requirements. All of BaroFold's units have successfully completed multiple GMP development runs for clinical supply and are available for licensing.
|
|
|
|
|
|
|
|
|
|
BaroFold
|
|
Health Care Equipment & Services
|
private:barofold
|
2394815
|
Feb 12th, 2018 12:00AM
|
BaroFold, Inc.
|
98
|
5.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
BaroFold was founded in 2009 by Matt Brewer and Matt Seefeldt through the acquisitions of a new company and is based on the patented PreEMT technology invented at the University of Colorado in the laboratories of Dr. Ted Randolph and Dr. John Carpenter. The Company is located at the Fitzsimons Bioscience Park in Aurora, CO and enjoys ample access to talented researchers within the biotech corridor between Denver and Boulder.
BaroFold provides the leading solution for solving the challenges of protein refolding and aggregation and enables E coli cytoplasmic expression to be the most efficient and cost effective expression technology when glycosylation is not required. BaroFold’s contract research services leverage a scalable, cGMP validated, Pressure Enabled Protein Manufacturing Technology (PreEMT™) for accelerating biologic drug development by reversing protein aggregation.
BaroFold helps companies create novel protein therapeutics, accelerate therapeutic protein development and manufacture follow-on biologics where access to a novel process technology is critical.
BaroFold manufactures state of the art PreEMT units for laboratory research and client clinical production requirements. All of BaroFold's units have successfully completed multiple GMP development runs for clinical supply and are available for licensing.
|
|
|
|
|
|
|
|
|
|
BaroFold
|
|
Health Care Equipment & Services
|
private:barofold
|
2394815
|
Feb 11th, 2018 12:00AM
|
BaroFold, Inc.
|
98
|
5.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
BaroFold was founded in 2009 by Matt Brewer and Matt Seefeldt through the acquisitions of a new company and is based on the patented PreEMT technology invented at the University of Colorado in the laboratories of Dr. Ted Randolph and Dr. John Carpenter. The Company is located at the Fitzsimons Bioscience Park in Aurora, CO and enjoys ample access to talented researchers within the biotech corridor between Denver and Boulder.
BaroFold provides the leading solution for solving the challenges of protein refolding and aggregation and enables E coli cytoplasmic expression to be the most efficient and cost effective expression technology when glycosylation is not required. BaroFold’s contract research services leverage a scalable, cGMP validated, Pressure Enabled Protein Manufacturing Technology (PreEMT™) for accelerating biologic drug development by reversing protein aggregation.
BaroFold helps companies create novel protein therapeutics, accelerate therapeutic protein development and manufacture follow-on biologics where access to a novel process technology is critical.
BaroFold manufactures state of the art PreEMT units for laboratory research and client clinical production requirements. All of BaroFold's units have successfully completed multiple GMP development runs for clinical supply and are available for licensing.
|
|
|
|
|
|
|
|
|
|
BaroFold
|
|
Health Care Equipment & Services
|
private:barofold
|
2394815
|
Feb 10th, 2018 12:00AM
|
BaroFold, Inc.
|
98
|
5.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
BaroFold was founded in 2009 by Matt Brewer and Matt Seefeldt through the acquisitions of a new company and is based on the patented PreEMT technology invented at the University of Colorado in the laboratories of Dr. Ted Randolph and Dr. John Carpenter. The Company is located at the Fitzsimons Bioscience Park in Aurora, CO and enjoys ample access to talented researchers within the biotech corridor between Denver and Boulder.
BaroFold provides the leading solution for solving the challenges of protein refolding and aggregation and enables E coli cytoplasmic expression to be the most efficient and cost effective expression technology when glycosylation is not required. BaroFold’s contract research services leverage a scalable, cGMP validated, Pressure Enabled Protein Manufacturing Technology (PreEMT™) for accelerating biologic drug development by reversing protein aggregation.
BaroFold helps companies create novel protein therapeutics, accelerate therapeutic protein development and manufacture follow-on biologics where access to a novel process technology is critical.
BaroFold manufactures state of the art PreEMT units for laboratory research and client clinical production requirements. All of BaroFold's units have successfully completed multiple GMP development runs for clinical supply and are available for licensing.
|
|
|
|
|
|
|
|
|
|
BaroFold
|
|
Health Care Equipment & Services
|